| Year |
Citation |
Score |
| 2015 |
Atabay KD, Yildiz MT, Avsar T, Karabay A, Kiliç T. Knockdown of Pin1 leads to reduced angiogenic potential and tumorigenicity in glioblastoma cells. Oncology Letters. 10: 2385-2389. PMID 26622856 DOI: 10.3892/Ol.2015.3512 |
0.371 |
|
| 2013 |
Karal-Yilmaz O, Ozkan A, Akgun E, Kukut M, Baysal K, Avsar T, Kilic T. Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis. Journal of Materials Science. Materials in Medicine. 24: 147-53. PMID 23053813 DOI: 10.1007/S10856-012-4784-2 |
0.341 |
|
| 2012 |
Yener U, Avsar T, Akgün E, Şeker A, Bayri Y, Kılıç T. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay. Journal of Neurosurgery. 117: 697-704. PMID 22900848 DOI: 10.3171/2012.6.Jns112263 |
0.321 |
|
| 2011 |
Avsar T, Akgun E, Yılmaz OK, Küküt M, Baysal K, Bayir Y, Seker A, Kilic T. Abstract B48: Inhibition of recurrence of craniopharyngiomas with imatinib mesylate-loaded poly(lactide-co-glycolide) (PLGA) microspheres Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-B48 |
0.333 |
|
| 2011 |
Avsar T, Atabay KD, Mehmet YT, Kilic T, Karabay AK. Abstract A31: Effects of Pin1 inhibition on tumorigenicity of glioblastoma multiforme Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A31 |
0.393 |
|
| 2011 |
Avsar T, Yener U, Akgun E. Abstract A30: Investigation of imatinib mesylate effect on vestibular schwannoma tumor by using in vivo corneal angiogenesis model Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A30 |
0.353 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Avsar T, Durası İM, Uygunoğlu U, Tütüncü M, Demirci NO, Saip S, Sezerman OU, Siva A, Tahir Turanlı E. CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes. Plos One. 10: e0122045. PMID 25942430 DOI: 10.1371/Journal.Pone.0122045 |
0.299 |
|
| 2014 |
Villar LM, Casanova B, Ouamara N, Comabella M, Jalili F, Leppert D, de Andrés C, Izquierdo G, Arroyo R, Avşar T, Lapin SV, Johnson T, Montalbán X, Fernández O, Álvarez-Lafuente R, et al. Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis. Annals of Neurology. 76: 231-40. PMID 24909126 DOI: 10.1002/Ana.24190 |
0.296 |
|
| 2019 |
Youngblood MW, Duran D, Montejo JD, Li C, Omay SB, Özduman K, Sheth AH, Zhao AY, Tyrtova E, Miyagishima DF, Fomchenko EI, Hong CS, Clark VE, Riche M, Peyre M, et al. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. Journal of Neurosurgery. 1-10. PMID 31653806 DOI: 10.3171/2019.8.Jns191266 |
0.291 |
|
| 2020 |
Tutumlu G, Dogan B, Avsar T, Orhan MD, Calis S, Durdagi S. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2. Frontiers in Chemistry. 8: 167. PMID 32328476 DOI: 10.3389/Fchem.2020.00167 |
0.282 |
|
| 2020 |
Avsar T, Sursal A, Turan G, Yigit BN, Altunsu D, Cantasir K, Duyu G, Bayoumi AB, Yapicier O, Acar M, Kilic T. Development of a Rapid and Sensitive IDH1/2 Mutation Detection Method for Glial Tumors and a Comparative Mutation Analysis of 236 Glial Tumor Samples. Molecular Diagnosis & Therapy. PMID 32274701 DOI: 10.1007/S40291-020-00461-Y |
0.279 |
|
| 2020 |
Aydin G, Paksoy MN, Orhan MD, Avsar T, Yurtsever M, Durdagi S. Proposing novel MDM2 inhibitors: Combined physics-driven high-throughput virtual screening and in vitro studies. Chemical Biology & Drug Design. 96: 684-700. PMID 32691963 DOI: 10.1111/Cbdd.13694 |
0.27 |
|
| 2012 |
Avsar T, Korkmaz D, Tütüncü M, Demirci NO, Saip S, Kamasak M, Siva A, Turanli ET. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1081-91. PMID 22252467 DOI: 10.1177/1352458511433303 |
0.268 |
|
| 2013 |
Kılıç K, Avsar T, Akgün E, Özkan A, Toktaş ZO, Şeker A, Kılıç T. Gamma knife radiosurgery inhibits angiogenesis of meningiomas: in vivo rat corneal assay. World Neurosurgery. 80: 598-604. PMID 23851230 DOI: 10.1016/J.Wneu.2013.06.021 |
0.265 |
|
| 2019 |
Li C, Tyrtova E, Youngblood M, Miyagishima D, Duran D, Montejo J, Özduman K, Sheth A, Zhao A, Fomchenko E, Clark V, Sohrabi S, Koljaka S, Li X, Pamir MN, et al. Mngi-09. Meningioma With Multiple Drivers: Genomic Landscape And Clinical Correlations Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.591 |
0.258 |
|
| 2015 |
Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Costa GD, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, ... ... Avsar T, et al. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 1013-24. PMID 25680984 DOI: 10.1177/1352458514568827 |
0.258 |
|
| 2022 |
Calis S, Dogan B, Durdagi S, Celebi A, Yapicier O, Kilic T, Turanli ET, Avsar T. A novel BH3 mimetic Bcl-2 inhibitor promotes autophagic cell death and reduces in vivo Glioblastoma tumor growth. Cell Death Discovery. 8: 433. PMID 36309485 DOI: 10.1038/s41420-022-01225-9 |
0.257 |
|
| 2020 |
Youngblood MW, Miyagishima DF, Jin L, Gupte T, Li C, Duran D, Montejo JD, Zhao A, Sheth A, Tyrtova E, Özduman K, Iacoangeli F, Peyre M, Boetto J, Pease M, et al. Associations of Meningioma Molecular Subgroup and Tumor Recurrence. Neuro-Oncology. PMID 33068421 DOI: 10.1093/neuonc/noaa226 |
0.249 |
|
| 2014 |
Ceylan D, Tatarlı N, Avsar T, Arslanhan A, Bozkurt SU, Bağcı P, Seker A, Kilic T. In vivo effect of pregnancy on angiogenesis potential of arteriovenous malformation tissue samples: an experimental study. Journal of Neurosurgical Sciences. PMID 25336049 DOI: 10.23736/S0390-5616.16.03085-X |
0.236 |
|
| 2022 |
Tatarli N, Ceylan D, Oksal MD, Avsar T, Kilic T. Antiangiogenic Molecules Suppressed Meningioma-Induced Neovascularization: A Corneal Angiogenesis Study. Turkish Neurosurgery. PMID 35929040 DOI: 10.5137/1019-5149.JTN.34777-21.4 |
0.229 |
|
| 2020 |
Kanan D, Kanan T, Dogan B, Orhan MD, Avsar T, Durdagi S. An Integrated In Silico Approach and In Vitro Study for the Discovery of USP7 Small Molecule Inhibitors as Potential Cancer Therapies. Chemmedchem. PMID 33063944 DOI: 10.1002/cmdc.202000675 |
0.218 |
|
| 2022 |
Avsar T, Kose TB, Oksal MD, Turan G, Kilic T. IDH1 mutation activates mTOR signaling pathway, promotes cell proliferation and invasion in glioma cells. Molecular Biology Reports. PMID 35934766 DOI: 10.1007/s11033-022-07750-1 |
0.206 |
|
| 2021 |
Durdagi S, Avsar T, Orhan MD, Serhatli M, Balcioglu BK, Ozturk HU, Kayabolen A, Cetin Y, Aydinlik S, Bagci-Onder T, Tekin S, Demirci H, Guzel M, Akdemir A, Calis S, et al. The neutralization effect of montelukaston SARS-CoV-2 is shown by multiscale in silicosimulations and combined in vitro studies. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34678509 DOI: 10.1016/j.ymthe.2021.10.014 |
0.204 |
|
| 2023 |
Degirmenci Z, Unver S, Kilic T, Avsar T. Silencing of the MEG3 gene promoted anti-cancer activity and drug sensitivity in glioma. Journal of Cellular and Molecular Medicine. 27: 2603-2613. PMID 37525401 DOI: 10.1111/jcmm.17883 |
0.203 |
|
| 2021 |
Sahin K, Orhan MD, Avsar T, Durdagi S. Hybrid and TR-FRET-Guided Discovery of Novel BCL-2 Inhibitors. Acs Pharmacology & Translational Science. 4: 1111-1123. PMID 34151203 DOI: 10.1021/acsptsci.0c00210 |
0.194 |
|
| 2021 |
Durdagi S, Orhan MD, Aksoydan B, Calis S, Dogan B, Sahin K, Shahraki A, Iyison NB, Avsar T. Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study. Molecular Informatics. e2100062. PMID 34529322 DOI: 10.1002/minf.202100062 |
0.182 |
|
| 2017 |
Durdagi S, Aksoydan B, Erol I, Kantarcioglu I, Ergun Y, Bulut G, Acar M, Avsar T, Liapakis G, Karageorgos V, Salmas RE, Sergi B, Alkhatib S, Turan G, Yigit BN, et al. Integration of multi-scale molecular modeling approaches with experiments for the in silico guided design and discovery of novel hERG-Neutral antihypertensive oxazalone and imidazolone derivatives and analysis of their potential restrictive effects on cell proliferation. European Journal of Medicinal Chemistry. 145: 273-290. PMID 29329002 DOI: 10.1016/J.Ejmech.2017.12.021 |
0.18 |
|
| 2023 |
Youngblood MW, Erson-Omay Z, Li C, Najem H, Coșkun S, Tyrtova E, Montejo JD, Miyagishima DF, Barak T, Nishimura S, Harmancı AS, Clark VE, Duran D, Huttner A, Avşar T, et al. Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas. Nature Communications. 14: 6279. PMID 37805627 DOI: 10.1038/s41467-023-41926-y |
0.166 |
|
| 2021 |
Avsar T, Mohiyuddin R, Calis S, Yapicier O, Kilic T. Association of MTHFR, MTRR and RAD54L Gene Variations with Meningioma and Correlation with Tumor's Histopathological Characteristics on Turkish Cohort. Turkish Neurosurgery. 31: 587-593. PMID 34169999 DOI: 10.5137/1019-5149.JTN.33347-20.2 |
0.148 |
|
| 2022 |
Sahkulubey Kahveci EL, Kahveci MU, Celebi A, Avsar T, Derman S. Glycopolymer and Poly(β-amino ester)-Based Amphiphilic Block Copolymer as a Drug Carrier. Biomacromolecules. 23: 4896-4908. PMID 36317475 DOI: 10.1021/acs.biomac.2c01076 |
0.145 |
|
| 2022 |
Cetin Y, Aydinlik S, Gungor A, Kan T, Avsar T, Durdagi S. Review on In silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2.. Current Medicinal Chemistry. PMID 35761502 DOI: 10.2174/0929867329666220627121416 |
0.144 |
|
| 2022 |
Erol E, Orhan MD, Avsar T, Akdemir A, Okudan ES, Alim Toraman GO, Topcu G. Anti-SARS-CoV-2 and cytotoxic activity of two marine alkaloids from green alga Sonder in the Dardanelles. Rsc Advances. 12: 29983-29990. PMID 36321101 DOI: 10.1039/d2ra03358e |
0.133 |
|
| 2021 |
Durdagi S, Dağ Ç, Dogan B, Yigin M, Avsar T, Buyukdag C, Erol I, Ertem FB, Calis S, Yildirim G, Orhan MD, Guven O, Aksoydan B, Destan E, Sahin K, et al. Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing. Structure (London, England : 1993). PMID 34403647 DOI: 10.1016/j.str.2021.07.007 |
0.128 |
|
| 2023 |
Everest E, Uygunoglu U, Tutuncu M, Bulbul A, Onat UI, Unal M, Avsar T, Saip S, Bilge U, Turanli ET, Siva A. Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers. Plos One. 18: e0287463. PMID 37339131 DOI: 10.1371/journal.pone.0287463 |
0.127 |
|
| 2021 |
Dogan K, Erol E, Didem Orhan M, Degirmenci Z, Kan T, Gungor A, Yasa B, Avsar T, Cetin Y, Durdagi S, Guzel M. Instant determination of the artemisinin from various Artemisia annua L. extracts by LC-ESI-MS/MS and their in-silico modelling and in vitro antiviral activity studies against SARS-CoV-2. Phytochemical Analysis : Pca. PMID 34585460 DOI: 10.1002/pca.3088 |
0.119 |
|
| 2021 |
Avşar T, Çelikyapi Erdem G, Terzioğlu G, Tahir Turanli E. Investigation of neuro-inflammatory parameters in a cuprizone induced mouse model of multiple sclerosis. Turkish Journal of Biology = Turk Biyoloji Dergisi. 45: 644-655. PMID 34803461 DOI: 10.3906/biy-2104-88 |
0.114 |
|
| 2020 |
AvŞar T, ÇaliŞ Ş, Yilmaz B, Demİrcİ OtluoĞlu G, Holyavkİn C, KiliÇ T. Genome-wide identification of Chiari malformation type I associated candidate genes and chromosomal variations. Turkish Journal of Biology = Turk Biyoloji Dergisi. 44: 449-456. PMID 33402871 DOI: 10.3906/biy-2009-19 |
0.112 |
|
| 2023 |
Cosan F, Demirel OU, Yalcin D, Sonkaya MM, Uluisik IE, Cecen O, Furuncuoglu Y, Celikmen DM, Kara O, Ceylan E, Avsar T. Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy. Bmc Rheumatology. 7: 20. PMID 37468956 DOI: 10.1186/s41927-023-00342-x |
0.062 |
|
| 2013 |
Yener U, Avsar T, Akgün E, Şeker A, Bayri Y, Kılıç T. Response. Journal of Neurosurgery. 119: 1353. PMID 24344455 |
0.01 |
|
| Hide low-probability matches. |